By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AbbVie 



      U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.


Key Statistics


Email:
Ownership: Public

Web Site: AbbVie
Employees:
Symbol: ABBV
 



Industry
Pharmaceutical






Company News
Repros Therapeutics Inc. (RPRX)'s Testosterone Drug Found Superior To AbbVie (ABBV)'s Androgel In Study 8/28/2014 6:09:13 AM
AbbVie (ABBV) Cystic Fibrosis Scholarship Program Awards 40 Student Scholars With Annual Academic Awards 8/18/2014 9:25:01 AM
Healthy Trucking Association of America, OraSure Technologies, Inc. (OSUR) And AbbVie (ABBV) Team Up To Launch Hepatitis C Awareness Campaign At The Great American Trucking Show 8/15/2014 8:41:46 AM
AbbVie (ABBV) Decides Against Appealing A Ruling That Would Have Protected Gays 8/7/2014 6:16:49 AM
AbbVie (ABBV)'s Brain Tumor Drug Gets U.S., EU Orphan Designation 8/4/2014 7:33:50 AM
AbbVie (ABBV) And Cystic Fibrosis Research, Inc. (CFRI) Team Up To Raise Awareness Of The Nutritional Needs Of CF Patients Through The Cfchef Shares Program 8/1/2014 10:58:14 AM
AbbVie (ABBV) Reports Second-Quarter 2014 Financial Results 7/25/2014 8:58:17 AM
AbbVie (ABBV) Trod Cautiously In Inversion Takeover Bid To Woo Drug Maker Shire 7/25/2014 6:46:34 AM
AbbVie (ABBV) To Host Second-Quarter Earnings Conference Call 7/23/2014 1:27:22 PM
AbbVie (ABBV) Finally Clinches Shire For $54 Billion 7/18/2014 6:53:49 AM
12345678910...
//-->